...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Reference values for a homogeneous Ferritin assay and traceability to the 3rd International Recombinant Standard for Ferritin (NIBSC code 94/572).
【24h】

Reference values for a homogeneous Ferritin assay and traceability to the 3rd International Recombinant Standard for Ferritin (NIBSC code 94/572).

机译:均质铁蛋白测定的参考值和对第三种国际铁蛋白重组标准(NIBSC代码94/572)的可追溯性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Reference values for two ferritin assays (Tina-quanta Ferritin, Enzymun, both Roche Diagnostics, Mannheim, Germany) were established (136 males and 139 females). To rule out inflammation as well as iron deficiency in the reference population, subjects with the C-reactive protein concentration < 5 mg/l, and zinc protoporphyrin < 40 micromol/mol heme and the soluble transferrin receptor < 3 mg/l were selected. Taking into account latent iron deficiency as well as hereditary hemochromatosis the 5-95 percentile range was as follows: male, 27-365 microg/l; female, 13-148 microg/l for Tina-quanta and 12-151 microg/l for Enzymun. The Tina-quanta Ferritin assay showed a very good correlation (r > or = 0.990) to Enzymun ferritin, Ferritin Abbott (Abbott Diagnostics, Delkenheim, Germany), N Latex Ferritin (Dade Behring, Marburg, Germany) and the Ferritin Chiron (Chiron Diagnostics, Fernwald, Germany). However, the slopes of the standard principal component method analysis were calculated to be between 1.03 (Enzymun) and 1.41 (N Latex Ferritin). For four assays the median recovery of the 3rd International Recombinant Ferritin Standard (NIBSC 94/572) measured by serial dilution was 89-109%. The N Latex Ferritin assay recovered half of the target values. Because of the good correlation with other assays, a matrix effect is likely. The question arises whether the manufacturers' agreement on the recombinant ferritin standard would harmonize ferritin measurement.
机译:建立了两种铁蛋白测定的参考值(Tina-quanta铁蛋白,Enzymun,Roche Diagnostics,曼海姆,德国)(男136名,女139名)。为了排除参考人群中的炎症和铁缺乏,选择了C反应蛋白浓度<5 mg / l,原卟啉锌<40 micromol / mol血红素和可溶性转铁蛋白受体<3 mg / l的受试者。考虑到潜在铁缺乏症和遗传性血色素沉着病,其5-95%的范围如下:雄性,27-365 microg / l;雌性,蒂娜量为13-148微克/升,酶制剂为12-151微克/升。蒂娜量子铁蛋白测定结果与酶铁蛋白,铁蛋白雅培(Abbott Diagnostics,Delkenheim,德国),N乳胶铁蛋白(Dade Behring,德国马尔堡)和铁蛋白Chiron(Chiron)有很好的相关性(r>或= 0.990)诊断,德国芬瓦尔德)。但是,标准主成分法分析的斜率经计算介于1.03(酶)和1.41(N乳胶铁蛋白)之间。对于四种测定,通过连续稀释测量的第三国际重组铁蛋白标准品(NIBSC 94/572)的中值回收率为89-109%。 N乳胶铁蛋白测定回收了一半的目标值。由于与其他测定的良好相关性,可能会产生基质效应。出现的问题是,制造商就重组铁蛋白标准达成的协议是否会协调铁蛋白的测量。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号